XML 113 R95.htm IDEA: XBRL DOCUMENT v3.22.4
Investments in and Advances to Joint Ventures - Summary of Financial Information for Consolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule Of Equity Method Investments [Line Items]      
Current assets $ 1,719,783 $ 1,632,351  
Total assets 4,198,142 3,830,940  
Current liabilities 1,108,119 1,030,784  
Total liabilities 2,102,207 1,893,828  
Total joint venture equity 2,043,570 1,900,768  
Revenue 4,195,272 3,660,771 $ 3,918,946
Costs 3,248,550 2,807,950 3,042,087
Net income attributable to Parsons Corporation 96,664 64,072 98,541
Net income attributable to noncontrolling interests 29,901 24,880 20,380
Consolidated Joint Ventures      
Schedule Of Equity Method Investments [Line Items]      
Current assets 289,837 246,342  
Noncurrent assets 9,961 2,180  
Total assets 299,798 248,522  
Current liabilities 198,464 175,637  
Total liabilities 198,464 175,637  
Total joint venture equity 101,334 72,885  
Revenue 483,888 402,078 450,530
Costs 422,559 351,670 408,319
Net income attributable to Parsons Corporation 61,329 50,408 42,211
Net income attributable to noncontrolling interests $ 29,901 $ 24,880 $ 20,380